Nouvelles

An article by FiercePharma
August 17, 2016 - While U.S. lawmakers are out on summer vacation, the urgency to develop an effective Zika vaccine remains. And so HHS Secretary Sylvia Burwell has signed off on an $81 million fund allocation for federal agencies to continue...
Un article de l'OMS
August 16, 2016 - 16 AOÛT 2016 | GENÈVE - Le jour de la naissance est potentiellement le plus dangereux pour la mère comme pour son enfant. Chaque année dans le monde, 303 000 femmes meurent pendant la grossesse ou l’accouchement, 2,7 millions de...
An article by FiercePharma
August 15, 2016 - Teaching kids to share is usually a parental goal, but a new ad from Pfizer may have some parents rethinking the parameters. The first campaign for meningococcal group B vaccine Trumenba highlights the dangers of MenB, which can...
An article by FierceHealthcare
August 14, 2016 - The healthcare sector will never be able to get its costs under control unless it takes a close look at what every iota of delivering services will cost, according to a new report by Chilmark Research. "As the cost of care...
An article by FierceHealth
August 11, 2016 - In a letter to House Democratic Leader Nancy Pelosi, Burwell said the fight against Zika, which is frequently spread by mosquitoes, has taken on new urgency in light of the rising number of Zika cases in  Florida. As of Thursday...
Un article de Le Monde
August 10, 2016 - « Moustique, t’es dingue. Nous, on fait la fête. » L’inscription aura duré le temps d’un week-end. Dessinés à la craie devant le R House, un bar branché de Wynwood, le quartier des artistes, hipsters et touristes de Miami, en...
An article by FiercePharma
August 9, 2016 - German diabetes specialist Emperra has launched the first wireless insulin pen that transfers data to a patient’s blood glucose diary via Bluetooth. The CE-marked device is launching in Germany with an eye toward an FDA approval...
An article by FiercePharma
August 9, 2016 - Florida’s HedgePath Pharmaceuticals heralded a positive midstage study for its oral capsules designed to treat a complication associated with basal cell carcinoma. The oral regimen demonstrated effectiveness in reducing tumor size...
An article by FiercePharma
August 9, 2016 - GlaxoSmithKline ($GSK) has struck a Strimvelis deal in Europe. The gene therapy for “bubble boy” disease, only the second of its kind, raised questions about pricing and payment in the up-and-coming field--and GSK’s arrangement...
An article by FierceHealthcare
August 9, 2016 - Doctors in Japan were perplexed for months over the case of a woman with leukemia who did not take to any of the treatments prescribed to her--then IBM’s Watson took over and solved the mystery in minutes. The artificial...
An article by FierceBiotech
August 9, 2016 - Wellcome Trust-backed scientists have found a compound that treats three neglected parasitic diseases in mice: leishmaniasis, Chagas disease and sleeping sickness. The trio of diseases affects millions of people in Latin America,...
An article by FiercePharma
August 9, 2016 - Dynavax Technologies ($DVAX) has a new FDA Adcomm date for consideration of its hepatitis B vaccine, Heplisav-B, after the agency earlier this year pushed back its PDUFA to December 15 over safety concerns. The Berkeley, CA-based...
An article by FiercePharma
August 4, 2016 - Scientists have been developing vaccines that could stop disease outbreaks more quickly. Now, researchers at the Massachusetts Institute of Technology are moving ahead with easy-to-make experimental jabs that can ward off a...
An article by FiercePharma
August 3, 2016 - As the number of Zika cases continues to rise in the U.S., researchers at the National Institutes of Health are launching a clinical trial of a vaccine meant to ward off the virus and prevent serious complications in infants. The...
An article by FiercePharma
August 3, 2016 - Sanofi ($SNY) provided insight into the logistics hurdles faced by vaccine makers in China after distribution and sales rule changes made in response to illegal vaccine sales. The changes implemented recently--which were rooted in...
An article by FierceBiotech
August 3, 2016 - The companies behind biologic drugs argue that the branded drugs and their generic versions, dubbed biosimilars, are not interchangeable. But a new study suggests otherwise, at least for a class of biologics called TNF-α...
An article by FierceHealthcare
August 3, 2016 - An interactive broadband mapping tool created by the Federal Communications Commission will help ensure a lack of connectivity is no longer “a super-determinant of health,” according to FCC Commissioner Mignon L. Clyburn. The tool...
An article by FiercePharma
August 2, 2016 - Pfizer’s ($PFE) Prevnar 13 sales were down in Q2 after management laid out low projections for the vaccine in 2016. But things could pick up again for Prevnar thanks to a new FDA approval. Sales of Prevnar 13 fell 16% in Q2 2016...
An article by FierceBiotech
August 1, 2016 - GlaxoSmithKline ($GSK) has announced a major new joint venture with Verily--once Google Life Sciences--as the two join forces with the hope of creating the first generation of bioelectronic medicines for chronic diseases. GSK has...
An article by The New York Times
July 30, 2016 - Some of the most promising advances in cancer research in recent years involve treatments known as immunotherapy. These advances are spurring billions of dollars in investment by drug companies, and are leading to hundreds of...

Pages